Prime Global Research, Inc.

The Bronx, New York 10456-2102

1 studies enrolling now · 5 studies all time

What they study most

COVID-19, Cardiovascular Disease, Hypercholesterolemia, Respiratory Syncytial Virus Infections, Soft Tissue Injuries

Studies at this site

• A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease — Recruiting now
• REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels — Running, not enrolling
• Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy. — Completed
• Study of Obeldesivir in Nonhospitalized Participants With COVID-19 — Completed
• Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants with Minor Soft Tissue Injury — Completed